Track
:
Track 08:Regulatory Affairs and Submissions
Program Code:
252
Date:
Tuesday, June 25, 2013
Time:
1:45 PM to 3:15 PM
EST
Location:
206AB
CHAIR
:
Nancy D. Smith, PhD (SCHNON), Independent Consultor, United States
Nancy Smith, PhD, retired from CDER/FDA in 2009 after over 21 years. Nancy is past-Chair of the Biopharmaceutical Section of the American Statistical Association, and served as a DIA board member of from 2002-2008. She is currently an ORISE Fellow at FDA developing training for new reviewers.
SPEAKER
(S):
Mary Ann Slack, (SPKAGY), Deputy Director, Office of Strategic Programs, CDER, FDA, United States
Mark A. Gray, (SPKAGY), Director, Div of Data Management Services and Solutions, OBI, CDER, FDA, United States
Mark has over 30 years experience in Information Management including; software developer/project manager in CBER; Director of Applications Development & Services in CDER; and PDUFA IT Program Director. The Division of Data Management Services & Solutions manages CDER’s e-submissions program.
Stephen E. Wilson, DrPH (SCHAGY), Director, Division of Biometrics III, Office of Translational Science, CDER, FDA, United States
Dr. Wilson has worked as a Statistical Reviewer and Supervisory Mathematical Statistician in FDA/CDER for 24 years and is currently the Director of the Division of Biometrics III and a Captain in the USPHS. He received his doctorate in Biostatistics from UNC/Chapel Hill in 1984.
Description
CDER will present an update and report on PDUFA performance goals and requirements related to electronic submissions. These include the requirement of electronic submissions and development of clinical and nonclinical terminology standards.